Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8785056 | Advances in Radiation Oncology | 2016 | 10 Pages |
Abstract
Patients with favorable intermediate-risk cancer could likely be treated with dose-escalated radiation therapy without ADT. Patients with high-risk and unfavorable intermediate-risk cancer, perineural invasion, and PSA nadir â¥1ng/dL had worse outcomes and likely need distinct therapeutic approaches.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rafael MD, Elton Trigo MD, Ana Luiza PhD, Fabio MD, Daniel E. MD, Fernando Freire MD, Carlos Eduardo MD, Joao Luis MD, Heloisa PhD, Bernardo PhD,